The Role of Insulin Resistance in Patients With Heart Failure and Type 2 Diabetes (CARMET2)
The purpose of this cross-sectional comparative 2x2 trial study is to compare the degree of insulin resistance, myocardial function and selected metabolic parameters and to explore the pathophysiological mechanisms by which insulin resistance is implicated in development of chronic heart failure (HF) in patients with type 2 diabetes and prediabetes (T2D).
Investigators hypothesize that patients with heart failure will be insulin-resistant and will display metabolic abnormalities as patients with diabetes.
Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: The Role of Insulin Resistance in Patients With Heart Failure and Type 2 Diabetes
Estimated Enrollment: 100
Study Start Date: December 2013
Estimated Study Completion Date: December 2019
Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)
|Study start date||2013-12-01|